Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

11376
1
HUBSPOT INC HubSpot Reports 20% Revenue Growth, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11377
1
Texas Pacific Land Corp Texas Pacific Land Corporation Reports 9.9% Revenue Growth and 14.7% Net Income Increase in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11378
1
INTERPARFUMS INC Inter Parfums Reports 15.4% Revenue Growth, Improved Gross Margin and Operating Income in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11379
1
Janux Therapeutics, Inc. Janux Therapeutics Reports Significant Financial Developments, Net Loss Widens in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11380
1
Aligos Therapeutics, Inc. Aligos Therapeutics Reports Significant Financial Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11381
1
Clearwater Analytics Holdings, Inc. Clearwater Analytics Reports 22% Revenue Growth, Turnaround to Profitability in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11382
1
Service Properties Trust Service Properties Trust Reports Decline in Revenues and Net Income, Announces Plans to Sell Hotels and Reduce Cash Distribution

Via official filing (AI summary) | 7 months ago | 0 comments

11383
1
Verastem, Inc. Verastem Reports $10M Revenue, Net Loss of $66M in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11384
1
COHERENT CORP. Coherent Corp. Reports 28% Revenue Growth, Net Earnings Turnaround in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11385
1
PERRIGO Co plc Perrigo Reports Decline in Net Sales and Net Income for Q3 and Nine Months of Fiscal 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11386
1
TKO Group Holdings, Inc. TKO Group Holdings Reports 52% Revenue Growth, Net Income Decline in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11387
1
Keros Therapeutics, Inc. Keros Therapeutics Reports Revenue Growth, Increased Operating Expenses, and Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11388
1
Tenaya Therapeutics, Inc. Tenaya Therapeutics Reports Financial Results, Decrease in Cash and Cash Equivalents, and Progress in Product Pipeline

Via official filing (AI summary) | 7 months ago | 0 comments

11389
1
ORION ENERGY SYSTEMS, INC. Orion Energy Systems Reports Mixed Q2 2025 Results, Net Loss Improvement

Via official filing (AI summary) | 7 months ago | 0 comments

11390
1
Hess Midstream LP Hess Midstream LP Reports Strong Financial Performance in Q3 and 9M 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11391
1
Performance Food Group Co Performance Food Group Reports 3.2% Net Sales Growth, Decline in Net Income for Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11392
1
INTEST CORP inTEST Corporation Reports Decline in Revenue and Profitability Amid Fluctuating Semiconductor Market

Via official filing (AI summary) | 7 months ago | 0 comments

11393
1
ACCURAY INC Accuray Reports 2% Revenue Decline, Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11394
1
FARO TECHNOLOGIES INC FARO Technologies Reports Mixed Q3 Results, Net Loss Improvement, and Restructuring Efforts

Via official filing (AI summary) | 7 months ago | 0 comments

11395
1
WORKIVA INC Workiva Reports 17.4% Revenue Growth, Net Loss Improvement in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11396
1
Trevi Therapeutics, Inc. Trevi Therapeutics Reports Significant Financial Decline, Net Loss of $13.2M in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

11397
1
Edwards Lifesciences Corp Edwards Lifesciences Reports Strong Financial Growth in Q3 and Nine Months of 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11398
1
DARLING INGREDIENTS INC. Darling Ingredients Reports Significant Decline in Financial Performance for Q3 and Nine Months of Fiscal 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11399
1
PHX MINERALS INC. PHX Minerals Reports Decline in Revenue and Profitability for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11400
1
Amplify Energy Corp. Amplify Energy Corp. Reports Significant Recovery in Profitability, Net Income Turnaround in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments